Corindus, A Siemens Healthineers Company, to Showcase CorPath® GRX Robotic System at EuroPCR 2022

NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today that it will showcase the CorPath GRX System, the first and only FDA-cleared and CE marked medical device for robotic-assisted coronary interventions, at EuroPCR 2022 through live cases, scientific presentations, and multiple Siemens Healthineers-sponsored symposia. One of the sessions, featuring Professor Dariusz Dudek from the Institute of Cardiology
Click here to view original post